MassMutual Private Wealth & Trust’s Roivant Sciences ROIV Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.7K	Buy	1,066 +162	+18%	+$4.79K	﹤0.01%	882
2026 Q1	$25K	Buy	904 +100	+12%	+$2.57K	﹤0.01%	1010
2025 Q4	$17.4K	Buy	804 +159	+25%	+$3.14K	﹤0.01%	1171
2025 Q3	$9.76K	Sell	645 -36	-5%	-$446	﹤0.01%	1409
2025 Q2	$7.67K	Buy	681 +276	+68%	+$2.99K	﹤0.01%	1467
2025 Q1	$4.09K	Buy	405 +196	+94%	+$2.12K	﹤0.01%	1677
2024 Q4	$2.47K	Buy	+209	New	+$2.47K	﹤0.01%	1765

Other funds holding ROIV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

MassMutual Private Wealth & Trust's ROIV Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Roivant Sciences (ROIV) stake by 18% in Q2 2026, buying an estimated $4.79K and bringing the position to 1,066 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

MassMutual Private Wealth & Trust first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. 159 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

MassMutual Private Wealth & Trust held 1,066 shares of Roivant Sciences worth $37.7K as of Q2 2026.
MassMutual Private Wealth & Trust bought 162 Roivant Sciences shares in Q2 2026, an estimated $4.79K.
Roivant Sciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #882 holding.
MassMutual Private Wealth & Trust first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
159 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.